To gain more insight into the dynamics of the ex vivo target engagement of RD2 in human AD brain homogenate, we monitored the Aβ oligomer concentration in diluted homogenates from four different AD patients with incubation times ranging from 0 to 23 h. The gene discussed is PRPH2; the disease is Alzheimer disease.